Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer Andrew X. ZhuJeffrey W. ClarkMatthew H. Kulke Original Article 20 June 2006 Pages: 285 - 293
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG) W. YeoM. BoyerA. T. C. Chan Original Article 17 June 2006 Pages: 295 - 300
Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin Goli SamimiShuichi KishimotoStephen B. Howell Original Article 13 June 2006 Pages: 301 - 312
A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer Hei-Cheul JeungSun Young RhaHyun Cheol Chung Original Article 13 June 2006 Pages: 313 - 320
Adsorption of irinotecan onto oral adsorbent AST-120 (KremezinTM) for preventing delayed diarrhea Muneaki HidakaKeishi YamasakiKazuhiko Arimori Original Article 13 June 2006 Pages: 321 - 328
A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells Takeshi KawanoNaoki AgataDonald Kufe Original Article 08 July 2006 Pages: 329 - 335
Irinotecan changes gene expression in the small intestine of the rat with breast cancer Joanne M. BowenRachel J. GibsonDorothy M. K. Keefe Original Article 24 June 2006 Pages: 337 - 348
cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib Michele BianchiniGiovanni MartinelliIrene Larripa Original Article 29 September 2006 Pages: 349 - 360
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma M. ReniS. CeredaV. Di Carlo Original Article 29 June 2006 Pages: 361 - 367
Cisplatin’s tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng Han H. AungSangeeta R. MehendaleChun-Su Yuan Original Article 24 June 2006 Pages: 369 - 374
Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model Enrico P. SpugniniAlfonso BaldiAlessandro Porrello Original Article 29 June 2006 Pages: 375 - 381
Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring Moon-Koo ChungChoong-Yong KimJong-Choon Kim Original Article 01 August 2006 Pages: 383 - 395
MZ3 induces apoptosis in human leukemia cells Liang FangQiaojun HeBo Yang Original Article 10 August 2006 Pages: 397 - 405
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients Walter J. LoosRonald de WitJaap Verweij Original Article 19 October 2006 Pages: 407 - 412
TEXAS (Taxotere® EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC K. MalinovszkyS. JohnstonR. Leonard Clinical Trial Report 29 September 2006 Pages: 413 - 418